Skip to content

Press Release · Press Releases · Asia-Pacific

GlycoNex Announces Japanese Regulatory Submission for Denosumab Biosimilar SPD8

Issued by PR Newswire

Image: PR Newswire

Regulatory decision in Japan anticipated as early as the end of 2027, subject to PMDA review; GlycoNex continues to seek partners for markets outside Japan NEW TAIPEI CITY, Nov. 8, 2026 /PRNewswire/ -- GlycoNex, Inc. (TPEx: 4168), a clinical-stage biotechnology company developing...

This press release summary is reproduced from the issuer's public feed.

Read the full release at PR Newswire

Original publisher: PR Newswire

Spotted an error? Request a correction · Corrections Policy

Related stories